Prospective Comparison of <sup>18</sup> F-Fluoromethylcholine Versus <sup>68</sup> Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy

2015564 citationsJournal Articlebronze Open Access

Authors

Joshua James Morigi · St Vincent's Hospital Sydney

Phillip D. Stricker · St Vincent's Clinic

Pim J. van Leeuwen · St Vincent's Clinic

Reuben Tang · UNSW Sydney

Bao Ho · St Vincent's Hospital Sydney

Quoc Nguyen · Garvan Institute of Medical Research

George Hruby ·

Abstract

In patients with biochemical failure and a low PSA level, (68)Ga-PSMA demonstrated a significantly higher detection rate than (18)F-fluoromethylcholine and a high overall impact on management.

Topics & Keywords

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Prostate Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Nuclear Medicine

Volume 56, Issue 8, pp. 1185-1190

DOI: 10.2967/jnumed.115.160382

Field-Weighted Citation Impact: 61.23